Članki

Tihomir Tomašič ... [et al.]
Selective DNA gyrase inhibitors bElektronski vir emulti-target in silico profiling with 3D-pharmacophores
Pharmaceuticals, 2021, Vol. 14, iss. 8, str. 1-24
https://www.mdpi.com/1424-8247/14/8/789

Žan Toplak ... [et al.]
Molecular dynamics-derived pharmacophore model explaining the nonselective aspect of KV10.1 pore blockers

Jaka Dernovšek ... [et al.]
Structure-activity relationships of benzothiazole-based Hsp90 C-terminal-domain inhibitors
Pharmaceutics, 2021, Vol. 13, iss. 8, str. 1-31

https://www.mdpi.com/1999-4923/13/8/1283

Barbara Sterle Zorec ... [et al.]
Particle properties and drug metastable solubility of simvastatin containing PVP matrix particles prepared by electrospraying technique
European Journal of Pharmaceutical Sciences, 2021, Vol. 158, str. 1-10
https://www.sciencedirect.com/science/article/pii/S0928098720304371

Michele Protti ... [et al.]
VAMS and StAGE as innovative tools for the enantioselective determination of clenbuterol in urine by LC-MS/MS
Journal of pharmaceutical and biomedical analysis, 2021, Vol. 195, str. 1-8
https://www.sciencedirect.com/science/article/pii/S073170852031760X#!

Gabrijela Brzan Simenc ... [et al.]
Correlation between cerebral biomarkers and optic nerve sheath diameter in patients with severe preeclampsia
Hypertension in pregnancy, 2021, Vol. 40, iss. 1, str. 8-13
https://www.tandfonline.com/doi/full/10.1080/10641955.2020.1849275

Katarina Grabrijan, Nika Strašek & Stanislav Gobec
Monocyclic beta-lactams for therapeutic uses: a patent overview (2010-2020)
Expert opinion on therapeutic patents, 2021, Vol. 31, no. 3, str. 247-266
https://www.tandfonline.com/doi/full/10.1080/13543776.2021.1865919

Andrej Šterman ... [et al.]
Catalytic approach to diverse alpha - aminoboronic acid derivatives by iridium-catalyzed hydrogenation of trifluoroborate-iminiums
 Advanced Synthesis & Catalysis, 2021, Vol. 363, iss. 9, str. 2396-2402
https://onlinelibrary.wiley.com/doi/full/10.1002/adsc.202001350

Martina Durcik ... [et al.]
New dual ATP-competitive inhibitors of bacterial DNA gyrase and topoisomerase IV active against ESKAPE pathogens
European Journal of Medicinal Chemistry, 2021, Vol. 213, str. 1-22
https://www.sciencedirect.com/science/article/pii/S0223523421000490#!

Katarina Rede ... [et al.]
Can APIs that are poorly water- and oil-soluble benefit from incorporation into SMEDDS? The case of dipyridamole
European Journal of Lipid Science and Technology, 2021, Vol. 123, iss. 4, str. 1-11
https://onlinelibrary.wiley.com/doi/abs/10.1002/ejlt.202000303